The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
A Practical Review of Proteasome Pharmacology
Open accessAbstract
The ubiquitin proteasome system (UPS) degrades individual proteins in a highly regulated fashion and is responsible for the degradation of misfolded, damaged, or unneeded cellular proteins. During the past 20 years, investigators have established a critical role for the UPS in essentially every cellular process, including cell cycle progression, transcriptional regulation, genome integrity, apoptosis, immune responses, and neuronal plasticity. At the center of the UPS is the proteasome, a large and complex molecular machine containing a multicatalytic protease complex. When the efficiency of this proteostasis system is perturbed, misfolded and damaged protein aggregates can accumulate to toxic levels and cause neuronal dysfunction, which may underlie many neurodegenerative diseases. In addition, many cancers rely on robust proteasome activity for degrading tumor suppressors and cell cycle checkpoint inhibitors necessary for rapid cell division. Thus, proteasome inhibitors have proven clinically useful to treat some types of cancer, especially multiple myeloma. Numerous cellular processes rely on finely tuned proteasome function, making it a crucial target for future therapeutic intervention in many diseases, including neurodegenerative diseases, cystic fibrosis, atherosclerosis, autoimmune diseases, diabetes, and cancer. In this review, we discuss the structure and function of the proteasome, the mechanisms of action of different proteasome inhibitors, various techniques to evaluate proteasome function in vitro and in vivo, proteasome inhibitors in preclinical and clinical development, and the feasibility for pharmacological activation of the proteasome to potentially treat neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,237
Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue
de Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., & Appelmans, F. (1955) · Biochemical Journal · doi:10.1042/bj0600604 · Cited by 4,174
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 2×
“The A11+ oligomers bound to the outside of the 20S cylinder and stabilized the gate in the closed conformation.”
Backgroundde Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033 · cited 1×
“Break-down of endogenous (autophagy) and exogenous (heter-ophagy) material was believed to occur in lysosomes, the “ intracellular digestive system ” (de Duve and Wattiaux, 1966).”
BackgroundWang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S., & Walter, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80835-1 · Cited by 1,992
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817
Intracellular Protein Degradation in Mammalian and Bacterial Cells
Goldberg, A. L., & Dice, J. F. (1974) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.43.070174.004155 · Cited by 1,769
Recognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Folding proteins in fatal ways
Selkoe, D. J. (2003) · Nature · doi:10.1038/nature02264 · Cited by 1,417
Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., & Maniatis, T. (1995) · Genes & Development · doi:10.1101/gad.9.13.1586 · Cited by 1,290
How Proteolysis Drives the Cell Cycle
King, R. W., Deshaies, R. J., Peters, J.-M., & Kirschner, M. W. (1996) · Science · doi:10.1126/science.274.5293.1652 · Cited by 1,273
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010083 · Cited by 1,234
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
Hershko, A., Heller, H., Elias, S., & Ciechanover, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82050-x · Cited by 1,160
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Intracellular Protein Degradation in Mammalian and Bacterial Cells: Part 2
Goldberg, A. L., & St. John, A. C. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.003531 · Cited by 1,066
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., Sandhu, I., Ganly, P., Baker, B. W., Jackson, S. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516282 · Cited by 1,060
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 1,000
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
The logic of the 26S proteasome.
Collins, G. A., & Goldberg, A. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.023 · Cited by 933
DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES
Rock, K. L., & Goldberg, A. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.739 · Cited by 921
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
NF-κB as a Therapeutic Target in Multiple Myeloma
Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200360200 · Cited by 893
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Generation of Destabilized Green Fluorescent Protein as a Transcription Reporter
Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C.-C., & Kain, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34970 · Cited by 846
A gated channel into the proteasome core particle.
Groll, M., Glickman, M. H., Finley, D. J., Bajorek, M., Köhler, A., Moroder, L., Rubin, D. M., & Huber, R. (2000) · Nature Structural Biology · doi:10.1038/80992 · Cited by 810
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination
Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S.-I., Igarashi, K., Tamura, T., Tanaka, K., & Ichihara, A. (1992) · Nature · doi:10.1038/360597a0 · Cited by 783
Kuhn, D. J., Chen, Q., Voorhees, P. M., Strader, J. S., Shenk, K. D., Sun, C. M., Demo, S. D., Bennett, M. K., van Leeuwen, F. W. B., Chanan-Khan, A. A., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065888 · Cited by 768
Hershko, A., Ciechanover, A., Heller, H., Haas, A. L., & Rose, I. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.1783 · Cited by 765
The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x L
Chen, C., Edelstein, L. C., & Gélinas, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2687-2695.2000 · Cited by 760
Distinct Ubiquitin-Ligase Complexes Define Convergent Pathways for the Degradation of ER Proteins
Carvalho, P., Goder, V., & Rapoport, T. A. (2006) · Cell · doi:10.1016/j.cell.2006.05.043 · Cited by 724
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694
The Dynamic State of Body Constituents.
(1942) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1942.02010120168016 · Cited by 691
Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids
Adams, J., Behnke, M., Chen, S., Cruickshank, A. A., Dick, L. R., Grenier, L., Klunder, J. M., Ma, Y.-T., Plamondon, L., & Stein, R. L. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00029-8 · Cited by 685
Control of Enzyme Levels in Animal Tissues
Schimke, R. T., & Doyle, D. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.004433 · Cited by 679
Proteasome subunit Rpn13 is a novel ubiquitin receptor
Husnjak, K., Elsasser, S., Zhang, N., Chen, X., Randles, L., Shi, Y., Hofmann, K., Walters, K. J., Finley, D., & Dikic, I. (2008) · Nature · doi:10.1038/nature06926 · Cited by 660
A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes
Ciehanover, A., Hod, Y., & Hershko, A. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91249-4 · Cited by 648
Appelmans, F., Wattiaux, R., & De Duve, C. (1955) · Biochemical Journal · doi:10.1042/bj0590438 · Cited by 632
Multiple Associated Proteins Regulate Proteasome Structure and Function
Leggett, D. S., Hanna, J., Borodovsky, A., Crosas, B., Schmidt, M., Baker, R. T., Walz, T., Ploegh, H., & Finley, D. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00638-x · Cited by 631
Muchamuel, T., Basler, M., Aujay, M. A., Suzuki, E., Kalim, K. W., Lauer, C., Sylvain, C., Ring, E. R., Shields, J., Jiang, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1978 · Cited by 599
Regulation of CD8 + T Cell Development by Thymus-Specific Proteasomes
Murata, S., Sasaki, K., Kishimoto, T., Niwa, S.-I., Hayashi, H., Takahama, Y., & Tanaka, K. (2007) · Science · doi:10.1126/science.1141915 · Cited by 580
γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
Gaczynska, M., Rock, K. L., & Goldberg, A. L. (1993) · Nature · doi:10.1038/365264a0 · Cited by 570
Etlinger, J. D., & Goldberg, A. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.1.54 · Cited by 563
Ciechanover, A., Heller, H., Elias, S., Haas, A. L., & Hershko, A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1365 · Cited by 562
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., & Ballard, D. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11259 · Cited by 554
Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M., & Masucci, M. G. (2000) · Nature Biotechnology · doi:10.1038/75406 · Cited by 553
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548
Rabinovich, E., Kerem, A., Fröhlich, K.-U., Diamant, N., & Bar-Nun, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.626-634.2002 · Cited by 546
Purification of two high molecular weight proteases from rabbit reticulocyte lysate.
Hough, R., Pratt, G., & Rechsteiner, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47564-3 · Cited by 545
Ciechanover, A., Finley, D., & Varshavsky, A. (1984) · Cell · doi:10.1016/0092-8674(84)90300-3 · Cited by 533
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Tai, H.-C., & Schuman, E. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2499 · Cited by 532
Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48
Jarosch, E., Taxis, C., Volkwein, C., Bordallo, J., Finley, D., Wolf, D. H., & Sommer, T. (2002) · Nature Cell Biology · doi:10.1038/ncb746 · Cited by 532
The Proteasome, a Novel Protease Regulated by Multiple Mechanisms
DeMartino, G. N., & Slaughter, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22123 · Cited by 530
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
Kisselev, A. F., van der Linden, W. A., & Overkleeft, H. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.003 · Cited by 527
Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85
Finley, D., Ciechanover, A., & Varshavsky, A. (1984) · Cell · doi:10.1016/0092-8674(84)90299-x · Cited by 522
Smith, D. M., Chang, S.-C., Park, S., Finley, D., Cheng, Y., & Goldberg, A. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.033 · Cited by 521
Self-citationFailure of the ubiquitin-proteasome system in Parkinson’s disease
McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519
Bennett, E. J., Bence, N. F., Jayakumar, R., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 509
Borodovsky, A., Kessler, B. M., Casagrande, R., Overkleeft, H. S., Wilkinson, K. D., & Ploegh, H. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5187 · Cited by 504
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Kupperman, E., Lee, E. C., Cao, Y., Bannerman, B., Fitzgerald, M., Berger, A., Yu, J., Yang, Y., Hales, P., Bruzzese, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2766 · Cited by 499
Regulation of proteasome activity in health and disease
Schmidt, M., & Finley, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.012 · Cited by 464
An unstructured initiation site is required for efficient proteasome-mediated degradation
Prakash, S., Tian, L., Ratliff, K. S., Lehotzky, R. E., & Matouschek, A. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb814 · Cited by 458
Oerlemans, R., Franke, N. E., Assaraf, Y. G., Cloos, J., van Zantwijk, I., Berkers, C. R., Scheffer, G. L., Debipersad, K., Vojtekova, K., Lemos, C., et al. (2008) · Blood · doi:10.1182/blood-2007-08-104950 · Cited by 454
Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control
Vashist, S., & Ng, D. T. W. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309132 · Cited by 449
Altered peptidase and viral-specific T cell response in LMP2 mutant mice
Van Kaert, L., Ashton-Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K. L., Goldberg, A. L., Doherty, P. C., & Tonegawa, S. (1994) · Immunity · doi:10.1016/1074-7613(94)90043-4 · Cited by 447
Signal-induced ubiquitination of Ikappa Balpha by the F-box protein Slimb/beta -TrCP
Spencer, E., Jiang, J., & Chen, Z. J. (1999) · Genes & Development · doi:10.1101/gad.13.3.284 · Cited by 431
Kisselev, A. F., Callard, A., & Goldberg, A. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509043200 · Cited by 416
Köhler, A., Cascio, P., Leggett, D. S., Woo, K. M., Goldberg, A. L., & Finley, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00274-x · Cited by 409
Arastu-Kapur, S., Anderl, J. L., Kraus, M., Parlati, F., Shenk, K. D., Lee, S. J., Muchamuel, T., Bennett, M. K., Driessen, C., Ball, A. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1950 · Cited by 408
20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
Borissenko, L., & Groll, M. (2007) · Chemical Reviews · doi:10.1021/cr0502504 · Cited by 407
In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment
Guo, Q., Lehmer, C., Martínez-Sánchez, A., Rudack, T., Beck, F., Hartmann, H., Pérez-Berlanga, M., Frottin, F., Hipp, M. S., Hartl, F. U., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.030 · Cited by 407
Arrigo, A.-P., Tanaka, K., Goldberg, A. L., & Welch, W. J. (1988) · Nature · doi:10.1038/331192a0 · Cited by 405
Regulatory functions of ubiquitination in the immune system
Ben-Neriah, Y. (2002) · Nature Immunology · doi:10.1038/ni0102-20 · Cited by 402
Dimopoulos, M. A., Goldschmidt, H., Niesvizky, R., Joshua, D., Chng, W.-J., Oriol, A., Orlowski, R. Z., Ludwig, H., Facon, T., Hajek, R., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30578-8 · Cited by 401
Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes.
Wilkinson, K. D., Urban, M. K., & Haas, A. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43857-x · Cited by 399
Proteasomal Inhibition by α-Synuclein Filaments and Oligomers
Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 397
The Importance of Both Synthesis and Degradation in the Control of Arginase Levels in Rat Liver
SCHIMKE, R. T. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91209-3 · Cited by 395
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., & LaFerla, F. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.014 · Cited by 384
Mechanism of Gate Opening in the 20S Proteasome by the Proteasomal ATPases
Rabl, J., Smith, D. M., Yu, Y., Chang, S.-C., Goldberg, A. L., & Cheng, Y. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.004 · Cited by 382
Self-citationMobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors
Rechsteiner, M., & Hill, C. P. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.11.003 · Cited by 371
Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy
Goldberg, A. L. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350012 · Cited by 367
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Thibaudeau, T. A., Anderson, R. T., & Smith, D. M. (2018) · Nature Communications · doi:10.1038/s41467-018-03509-0 · Cited by 360
Self-citationHolbeck, S. L., Camalier, R., Crowell, J. A., Govindharajulu, J. P., Hollingshead, M., Anderson, L. W., Polley, E., Rubinstein, L., Srivastava, A., Wilsker, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0489 · Cited by 359
Evidence that Pituitary Cation‐Sensitive Neutral Endopeptidase Is a Multicatalytic Protease Complex
Wilk, S., & Orlowski, M. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb08056.x · Cited by 358
Kerckhove, N., Collin, A., Condé, S., Chaleteix, C., Pezet, D., & Balayssac, D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00086 · Cited by 350
An, B., Goldfarb, R. H., Siman, R., & Dou, Q. P. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400436 · Cited by 337
Mechanistic insights into ER-associated protein degradation
Wu, X., & Rapoport, T. A. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.04.004 · Cited by 334
Acetylation-Mediated Proteasomal Degradation of Core Histones during DNA Repair and Spermatogenesis
Qian, M.-X., Pang, Y., Liu, C. H., Haratake, K., Du, B.-Y., Ji, D.-Y., Wang, G.-F., Zhu, Q.-Q., Song, W., Yu, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.032 · Cited by 330
Braun, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.615 · Cited by 330
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327
PA200, a nuclear proteasome activator involved in DNA repair
Ustrell, V. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf333 · Cited by 326
"Covalent affinity" purification of ubiquitin-activating enzyme.
Ciechanover, A., Elias, S., Heller, H., & Hershko, A. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34957-3 · Cited by 320
Cation‐Sensitive Neutral Endopeptidase: Isolation and Specificity of the Bovine Pituitary Enzyme
Wilk, S., & Orlowski, M. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb07873.x · Cited by 316
Fonseca, R., Vabulas, R. M., Hartl, F. U., Bonhoeffer, T., & Nägerl, U. V. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.015 · Cited by 310
HRD4/NPL4 Is Required for the Proteasomal Processing of Ubiquitinated ER Proteins
Bays, N. W., Wilhovsky, S. K., Goradia, A., Hodgkiss-Harlow, K., & Hampton, R. Y. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.12.4114 · Cited by 305
McNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 304
Arendt, C. S., & Hochstrasser, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7156 · Cited by 302
Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H., Calafat, J., Drijfhout, J. W., & Neefjes, J. (2003) · Immunity · doi:10.1016/s1074-7613(02)00511-3 · Cited by 299
Degradation of Abnormal Proteins in Escherichia coli
Goldberg, A. L. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.2.422 · Cited by 297
Development of proteasome inhibitors as research tools and cancer drugs
Goldberg, A. L. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201210077 · Cited by 291
Hershko, A., Eytan, E., Ciechanover, A., & Haas, A. L. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45327-1 · Cited by 290
Hough, R., Pratt, G., & Rechsteiner, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35950-1 · Cited by 286
Huyer, G., Piluek, W. F., Fansler, Z., Kreft, S. G., Hochstrasser, M., Brodsky, J. L., & Michaelis, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402468200 · Cited by 277
Dou, Q., & Zonder, J. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666140804154511 · Cited by 275
Ubiquitin-Independent Degradation of Cell-Cycle Inhibitors by the REGγ Proteasome
Chen, X., Barton, L. F., Chi, Y., Clurman, B. E., & Roberts, J. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.022 · Cited by 275
Zhou, H.-J., Aujay, M. A., Bennett, M. K., Dajee, M., Demo, S. D., Fang, Y., Ho, M. N., Jiang, J., Kirk, C. J., Laidig, G. J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801329v · Cited by 272
Bassermann, F., Eichner, R., & Pagano, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.028 · Cited by 268
The Unfolded Protein Response, Degradation from the Endoplasmic Reticulum, and Cancer
Tsai, Y. C., & Weissman, A. M. (2010) · Genes & Cancer · doi:10.1177/1947601910383011 · Cited by 267
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer
Shah, S. A., Potter, M. W., McDade, T. P., Ricciardi, R., Perugini, R. A., Elliott, P. J., Adams, J., & Callery, M. P. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1150 · Cited by 260
An Integrated Mass Spectrometry-based Proteomic Approach
Guerrero, C., Tagwerker, C., Kaiser, P., & Huang, L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500303-mcp200 · Cited by 258
Near-atomic resolution structural model of the yeast 26S proteasome
Beck, F., Unverdorben, P., Bohn, S., Schweitzer, A., Pfeifer, G., Sakata, E., Nickell, S., Plitzko, J. M., Villa, E., Baumeister, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213333109 · Cited by 253
Conformational switching of the 26S proteasome enables substrate degradation
Matyskiela, M. E., Lander, G. C., & Martin, A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2616 · Cited by 251
Smith, D. M., Kafri, G., Cheng, Y., Ng, D., Walz, T., & Goldberg, A. L. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.019 · Cited by 251
Self-citationGates, Channels, and Switches: Elements of the Proteasome Machine
Finley, D., Chen, X., & Walters, K. J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.009 · Cited by 251
Potential for proteasome inhibition in the treatment of cancer
Adams, J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02647-3 · Cited by 245
Ichikawa, H. T., Conley, T., Muchamuel, T., Jiang, J., Lee, S., Owen, T., Barnard, J., Nevarez, S., Goldman, B. I., Kirk, C. J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33333 · Cited by 244
Dynamic Regulation of Archaeal Proteasome Gate Opening As Studied by TROSY NMR
Religa, T. L., Sprangers, R., & Kay, L. E. (2010) · Science · doi:10.1126/science.1184991 · Cited by 240
Prevention of Rapid Intracellular Degradation of ODC by a Carboxyl-Terminal Truncation
Ghoda, L., van Daalen Wetters, T., Macrae, M., Ascherman, D., & Coffino, P. (1989) · Science · doi:10.1126/science.2928784 · Cited by 238
THE RELEASE OF LABELED AMINO ACIDS FROM THE PROTEINS OF RAT LIVER SLICES
Simpson, M. V. (1953) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71356-2 · Cited by 237
Selective control of the degradation of normal and aberrant proteins in Reuber H35 hepatoma cells
Knowles, S. E., & Ballard, F. J. (1976) · Biochemical Journal · doi:10.1042/bj1560609 · Cited by 236
hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37
Qiu, X., Ouyang, S., Li, C., Miao, S., Wang, L., & Goldberg, A. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601450 · Cited by 234
A transgenic mouse model of the ubiquitin/proteasome system
Lindsten, K., Menéndez-Benito, V., Masucci, M. G., & Dantuma, N. P. (2003) · Nature Biotechnology · doi:10.1038/nbt851 · Cited by 234
Stratton, R., Shiwen, X., Martini, G., Holmes, A., Leask, A., Haberberger, T., Martin, G. R., Black, C. M., & Abraham, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12020 · Cited by 232
Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae
Gilon, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2759 · Cited by 227
Peth, A., Besche, H. C., & Goldberg, A. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.015 · Cited by 211
Proteasome inhibition in cancer: Development of PS-341
ADAMS, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90034-x · Cited by 209
Central Pore Residues Mediate the p97/VCP Activity Required for ERAD
DeLaBarre, B., Christianson, J. C., Kopito, R. R., & Brunger, A. T. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.036 · Cited by 203
Protein quality control at the inner nuclear membrane
Khmelinskii, A., Blaszczak, E., Pantazopoulou, M., Fischer, B., Omnus, D. J., Le Dez, G., Brossard, A., Gunnarsson, A., Barry, J. D., Meurer, M., et al. (2014) · Nature · doi:10.1038/nature14096 · Cited by 198
Substrate access and processing by the 20S proteasome core particle
Groll, M., & Huber, R. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00390-4 · Cited by 195
Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach
Groll, M., & Huber, R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.025 · Cited by 193
Quality control of inner nuclear membrane proteins by the Asi complex
Foresti, O., Rodriguez-Vaello, V., Funaya, C., & Carvalho, P. (2014) · Science · doi:10.1126/science.1255638 · Cited by 185
The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle
Schmidt, M., Haas, W., Crosas, B., Santamaria, P. G., Gygi, S. P., Walz, T., & Finley, D. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb914 · Cited by 184
Unverdorben, P., Beck, F., Śledź, P., Schweitzer, A., Pfeifer, G., Plitzko, J. M., Baumeister, W., & Förster, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403409111 · Cited by 183
Kisselev, A. F., Kaganovich, D., & Goldberg, A. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112360200 · Cited by 180
Structural basis for dynamic regulation of the human 26S proteasome
Chen, S., Wu, J., Lu, Y., Ma, Y.-B., Lee, B.-H., Yu, Z., Ouyang, Q., Finley, D. J., Kirschner, M. W., & Mao, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614614113 · Cited by 176
Imaging 26S proteasome activity and inhibition in living mice
Luker, G. D., Pica, C. M., Song, J., Luker, K. E., & Piwnica-Worms, D. (2003) · Nature Medicine · doi:10.1038/nm894 · Cited by 174
Impaired ubiquitin–proteasome system activity in the synapses of Huntington's disease mice
Wang, J., Wang, C.-E., Orr, A., Tydlacka, S., Li, S.-H., & Li, X.-J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709080 · Cited by 169
Peth, A., Uchiki, T., & Goldberg, A. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.002 · Cited by 167
Structural insights into the functional cycle of the ATPase module of the 26S proteasome
Wehmer, M., Rudack, T., Beck, F., Aufderheide, A., Pfeifer, G., Plitzko, J. M., Förster, F. G., Schulten, K. J., Baumeister, W. P., & Sakata, E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621129114 · Cited by 166
The Ubiquitin-Proteasome System in Neurodegeneration
McKinnon, C., & Tabrizi, S. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5802 · Cited by 165
Tanaka, K., Waxman, L., & Goldberg, A. L. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.6.1580 · Cited by 163
Structure of a Blm10 Complex Reveals Common Mechanisms for Proteasome Binding and Gate Opening
Sadre-Bazzaz, K., Whitby, F. G., Robinson, H. H., Formosa, T., & Hill, C. P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.002 · Cited by 160
Sledz, P., Unverdorben, P., Beck, F., Pfeifer, G., Schweitzer, A., Förster, F. G., & Baumeister, W. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305782110 · Cited by 159
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11
Li, J., Yakushi, T., Parlati, F., Mackinnon, A. L., Perez, C., Ma, Y., Carter, K. P., Colayco, S., Magnuson, G., Brown, B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2326 · Cited by 159
Boselli, M. G., Lee, B., Robert, J., Prado, M. A., Min, S., Cheng, C., Silva, M. C., Seong, C., Elsasser, S., Hatle, K. M., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815126 · Cited by 153
Ramachandran, K. V., & Margolis, S. S. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3389 · Cited by 151
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Di, K., Lloyd, G. K., Abraham, V. M., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov299 · Cited by 148
Pickering, A. M., & Davies, K. J. A. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.04.018 · Cited by 147
Proteasome Activator PA200 Is Required for Normal Spermatogenesis
Khor, B., Bredemeyer, A. L., Huang, C., Turnbull, I. R., Evans, R., Maggi, L. B., White, J. M., Walker, L. M., Carnes, K. I., Hess, R. A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2999-3007.2006 · Cited by 147
Masdehors, P., Ōmura, S., Merle‐Béral, H., Mentz, F., Cosset, J., Dumont, J., Magdelénat, H., & Delić, J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01388.x · Cited by 143
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Buac, D., Shen, M., Schmitt, S. M., Kona, F. R., Deshmukh, R. R., Zhang, Z., Neslund-Dudas, C. M., Mitra, B., & Dou, Q. P. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319220012 · Cited by 141
Proteasome allostery as a population shift between interchanging conformers
Ruschak, A. M., & Kay, L. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213640109 · Cited by 140
Identification, Purification, and Characterization of a PA700-dependent Activator of the Proteasome
Demartino, G., Proske, R. J., Moomaw, C. R., Strong, A. A., Song, X., Hisamatsu, H., Tanaka, K., & Slaughter, C. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3112 · Cited by 140
Proteasome inhibitors as new anticancer drugs
Adams, J. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200211000-00007 · Cited by 140
Reconstitution of the 26S proteasome reveals functional asymmetries in its AAA+ unfoldase
Beckwith, R., Estrin, E., Worden, E. J., & Martin, A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2659 · Cited by 138
Spotlight on ixazomib: potential in the treatment of multiple myeloma
Azab, A. K., Muz, B., Ghazarian, R., Ou, M., Luderer, M. J., & Kusdono, H. D. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s93602 · Cited by 134
Meddling with Fate: The Proteasomal Deubiquitinating Enzymes
de Poot, S. A. H., Tian, G., & Finley, D. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.015 · Cited by 134
Díaz-Hernández, M., Valera, A. G., Morán, M. A., Gómez‐Ramos, P., Alvarez‐Castelao, B., Castaño, J. G., Hernández, F., & Lucas, J. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03968.x · Cited by 128
Role of proteasomes modified by interferon-γ in antigen processing
Tanaka, K. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.571 · Cited by 128
The unique functions of tissue-specific proteasomes
Kniepert, A., & Groettrup, M. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.10.004 · Cited by 127
Ubp6 deubiquitinase controls conformational dynamics and substrate degradation of the 26S proteasome
Bashore, C., Dambacher, C. M., Goodall, E. A., Matyskiela, M. E., Lander, G. C., & Martin, A. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3075 · Cited by 126
Deriziotis, P., André, R., Smith, D. M., Goold, R., Kinghorn, K. J., Kristiansen, M., Nathan, J. A., Rosenzweig, R., Krutauz, D., Glickman, M. H., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.224 · Cited by 126
Self-citationThe immunoproteasome: a novel drug target for autoimmune diseases.
Basler, M., Mundt, S., Bitzer, A., Schmidt, C., & Groettrup, M. (2015) · PubMed · Cited by 121
Aso, E., Lomoio, S., López‐González, I., Joda, L., Carmona, M., Fernández‐Yagüe, N., Moreno, J., Juvés, S., Pujol, A., Pamplona, R., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00560.x · Cited by 118
Schoenheimer, R., Ratner, S., & Rittenberg, D. (1939) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)73846-5 · Cited by 118
Consensus motifs and peptide ligands of MHC class I molecules
Falk, K., & Rötzschke, O. (1993) · Seminars in Immunology · doi:10.1006/smim.1993.1012 · Cited by 118
Proteasomes and their associated ATPases: A destructive combination
Smith, D. M., Benaroudj, N., & Goldberg, A. L. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.04.012 · Cited by 118
Self-citationCiechanover, A. J. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.056 · Cited by 116
Hao, M., Zhang, L., An, G., Meng, H., Han, Y.-J., Xie, Z., Xu, Y., Li, C., Yu, Z., Chang, H. H., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.576791 · Cited by 116
Phosphorylation of Rpt6 regulates synaptic strength in hippocampal neurons
Djakovic, S. N., Marquez-Lona, E. M., Jakawich, S. K., Wright, R., Chu, C., Sutton, M. A., & Patrick, G. N. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4427-11.2012 · Cited by 112
Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome
Wang, X., Cimermančič, P., Yu, C., Schweitzer, A., Chopra, N., Engel, J. D., Greenberg, C., Huszagh, A. S., Beck, F., Sakata, E., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.065326 · Cited by 112
The Axial Channel of the 20S Proteasome Opens Upon Binding of the PA200 Activator
Ortega, J., Heymann, J. B., Kajava, A. V., Ustrell, V., Rechsteiner, M., & Steven, A. C. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.12.049 · Cited by 110
Zhu, Y. X., Tiedemann, R. E., Shi, C.-X., Yin, H., Schmidt, J. E., Bruins, L. A., Keats, J. J., Braggio, E., Sereduk, C., Mousses, S., et al. (2011) · Blood · doi:10.1182/blood-2010-08-304022 · Cited by 110
Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 110
Yu, Y., Smith, D. M., Kim, H. M., Rodriguez, V. Z., Goldberg, A. L., & Cheng, Y. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.382 · Cited by 109
Self-citationStaff, N. P., Podratz, J. L., Grassner, L., Lange, M. L. B., Paz, J., Knight, A. M., Loprinzi, C. L., Trushina, E. V., & Windebank, A. J. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.09.001 · Cited by 108
Ubiquitin Fusion Technique and Related Methods
Varshavsky, A. J. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)99051-4 · Cited by 107
A photoconvertible reporter of the ubiquitin-proteasome system in vivo
Hamer, G., Matilainen, O., & Holmberg, C. I. (2010) · Nature Methods · doi:10.1038/nmeth.1460 · Cited by 104
Bigelow, S. S., Hough, R., & Rechsteiner, M. (1981) · Cell · doi:10.1016/0092-8674(81)90233-6 · Cited by 104
Carozzi, V., Canta, A., Oggioni, N., Sala, B., Chiorazzi, A., Meregalli, C., Bossi, M., Marmiroli, P., & Cavaletti, G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.09.004 · Cited by 101
Ubiquitinated Proteins Activate the Proteasomal ATPases by Binding to Usp14 or Uch37 Homologs
Peth, A., Kukushkin, N. V., Bosse, M. M., & Goldberg, A. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441907 · Cited by 101
Cited by
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Narayanan, S., Cai, C.-Y., Assaraf, Y. G., Guo, H.-Q., Cui, Q., Wei, L., Huang, J.-J., Ashby, C. R., & Chen, Z.-S. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100663 · Cited by 332
Fricker, L. D. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023603 · Cited by 309
Proteolysis‐targeting chimeras in drug development: A safety perspective
Moreau, K., Coen, M., Zhang, A. X., Pachl, F., Castaldi, M. P., Dahl, G., Boyd, H., Scott, C., & Newham, P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15014 · Cited by 229
Small-Molecule Degraders beyond PROTACs—Challenges and Opportunities
Kastl, J. M., Davies, G., Godsman, E., & Holdgate, G. A. (2021) · SLAS Discovery · doi:10.1177/2472555221991104 · Cited by 43
Cao, C., Wang, K., Wang, Y., Liu, T.-B., Rivera, A., & Xue, C. (2022) · Nature Communications · doi:10.1038/s41467-022-34151-6 · Cited by 18
Metadata
- Authors
- Thibaudeau, T. A., & Smith, D. M.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 71
- Issue
- 2
- Pages
- 170-197
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2921234630
- Cited by
- 344
- References
- 265
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.